4199-31-9

Basic information

• Product Name: (4S)-7-Chloro-4β-(dimethylamino)-1,4,4aβ,5,6,11,12,12aβ-octahydro-3,6,10,12a-tetrahydroxy-6α-methyl-1,11,12-trioxo-2-naphthacenecarboxamide
• Synonyms: (4S)-7-Chloro-4β-(dimethylamino)-1,4,4aβ,5,6,11,12,12aβ-octahydro-3,6,10,12a-tetrahydroxy-6α-methyl-1,11,12-trioxo-2-naphthacenecarboxamide
• CAS NO: 4199-31-9
• Molecular Formula: C22H21ClN2O8
• Molecular Weight: 476.86374
• Mol File: 4199-31-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4S)-7-Chloro-4β-(dimethylamino)-1,4,4aβ,5,6,11,12,12aβ-octahydro-3,6,10,12a-tetrahydroxy-6α-methyl-1,11,12-trioxo-2-naphthacenecarboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: (4S)-7-Chloro-4β-(dimethylamino)-1,4,4aβ,5,6,11,12,12aβ-octahydro-3,6,10,12a-tetrahydroxy-6α-methyl-1,11,12-trioxo-2-naphthacenecarboxamide(4199-31-9)
• EPA Substance Registry System: (4S)-7-Chloro-4β-(dimethylamino)-1,4,4aβ,5,6,11,12,12aβ-octahydro-3,6,10,12a-tetrahydroxy-6α-methyl-1,11,12-trioxo-2-naphthacenecarboxamide(4199-31-9)

Safety Data

• Hazardous Substances Data: 4199-31-9(Hazardous Substances Data)

Upstream product

• 4497-08-9 (4S,4aS,12aS)-7-chloro-4-(dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide 

Relevant articles and documents

METHODS FOR ENGINEERING THERAPEUTICS AND USES THEREOF

The disclosed subject matter provides for genetically modified cells, e.g, fungal cells, that autonomously generates and/or secretes one or more therapeutic molecules, e.g, therapeutic peptides, therapeutic proteins or small therapeutic molecules, in situ. In certain embodiments, the present disclosure provides genetically-engineered fungal cells that generate and secrete tetracycline and analogues thereof.